RT Journal Article SR Electronic T1 A Highly Generalizable Natural Language Processing Algorithm for the Diagnosis of Pulmonary Embolism from Radiology Reports JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2020.10.13.20211961 DO 10.1101/2020.10.13.20211961 A1 Jacob Johnson A1 Grace Qiu A1 Christine Lamoureux A1 Jennifer Ngo A1 Lawrence Ngo YR 2020 UL http://medrxiv.org/content/early/2020/10/14/2020.10.13.20211961.abstract AB Though sophisticated algorithms have been developed for the classification of free-text radiology reports for pulmonary embolism (PE), their overall generalizability remains unvalidated given limitations in sample size and data homogeneity. We developed and validated a highly generalizable deep-learning based NLP algorithm for this purpose with data sourced from over 2,000 hospital sites and 500 radiologists. The algorithm achieved an AUCROC of 0.995 on chest angiography studies and 0.994 on non-angiography studies for the presence or absence of PE. The high accuracy achieved on this large and heterogeneous dataset allows for the possibility of application in large multi-center radiology practices as well as for deployment at novel sites without significant degradation in performance.Competing Interest StatementLawrence Ngo and Jacob Johnson are Co-Founders of CoRead AI. Lawrence Ngo and Chrisitine Lamoureux work as radiologists for Virtual Radiologic.Funding StatementNo external funding was provided for this study.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved with a waiver of consent by Western IRB.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data from this study is not publically available.